Biosimilars are “me-too” drugs, not generics
Time to take off the blinders Time to take off the blinders Generic drugs
The Struggle for Consumer Attention: Brand-Name Drugs
“Is there a generic version of that?” “Is there a generic version of that?”
Are Biosimilars Ethical?
Generic drugs have been an effective cost containment solution for traditional, small molecule pharmaceuticals.
Pfizer Has a New Sales Strategy–Will Be
Well this stands to certainly keep more patients taking “name” brand Lipitor and on
Report: Branded Drug Use Sharply Down, Generics
A healthcare informatics company issues a report today that I really do not find